USRDS 2000 ADR USRDS Hepatitis B vaccine & antibody among patients & unit staff figure 9.1, dialysis patients, 1997, by network.

Slides:



Advertisements
Similar presentations
Risk Stratification in Renal Care Mary Jane McKendry Vice President, Operations Fresenius Disease Management Optimal Renal Care.
Advertisements

Dr. Weal Habhab,MD,FRCPC Nephrology Consultant Nephrology Section Head King Faisal Specialist Hospital -Jeddah.
Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access Theodore F. Saad, MD Nephrology Associates, PA Christiana Care Health.
Renal Replacement Therapy: What the PCP Needs to Know.
Chapter 4: Hospitalization 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
The State of CKD, ESRD and Mortality in the First Year on Dialysis: Are We Doing Enough? Allan J. Collins, MD, FACP Professor of Medicine University of.
Treated ESRD Incidence Rates for Selected Countries, New ESRD Patients/Million Pop. Year of ESRD Incidence USA (All) JPN* USA (White) CAN FRA NL.
Chapter 3: Clinical Indicators and Preventive Care 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 2: Healthy People A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Vol 2 Figure 1.1 Trends in the number of incident cases of ESRD, in thousands, by modality, in the U.S. population, Data Source: Reference.
Chapter 5: Mortality 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Gerard Dou, The Dropsical Woman, 1663, Louvre, Paris Peer Report: Dialysis Care & Outcomes in the U.S., 2014 Executive Summary.
| 1| 1Peer Report: Dialysis Care & Outcomes in the U.S., 2014 | Incidence Peer Report: Dialysis Care & Outcomes in the U.S., 2014 Incidence.
Number of Dialysis and Transplant Units by Year, Number of Units Total Dialysis Only Transplant USRDS 1999 XI-1 Year.
Healthy People 2010 Focus Area 4
1 Adult Hemodialysis Longitudinal Follow-Up Data 2002–2008.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 3: Clinical Indicators and Preventive Care.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 10: Dialysis Providers.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 5: Hospitalization.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 2: Healthy People 2020.
Chronic Kidney Disease (CKD) Healthy Kansans 2010.
ESRD Prognoses James Heaf. This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Similar Outcomes With Hemodialysis and Peritoneal.
USRDS USRDS 2002 adr Period prevalent ESRD patient, deaths, & ESRD expenditures figure 12.1.
USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
USRDS 2000 ADR USRDS Cadaveric donations by gender & race figure 7.1, patients aged
2016 Annual Data Report, Vol 2, ESRD, Ch 5
Figure 3.1 ESRD clinical indicators, CROWNWeb data, December 2015
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Healthy People 2010 targets & levels achieved in 2000 figure hp.1
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
First-year death rates by modality figure 8
Percent of patients receiving influenza vaccinations figure 5
Odd ratio of developing kidney failure figure 1
Patient populations by study group figure 10
Mortality rates in incident ESRD patients figure 9
Volume 2: End-Stage Renal Disease
2017 Annual Data Report Healthy People 2020.
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
December 31st point prevalent counts by modality figure 3.1
UK Renal Registry 18th Annual Report
Hospital admissions per patient, by modality figure 5
UK Renal Registry 9th Annual Report 2006
Chapter 2: Clinical Indicators and Preventive Care
سرطان الثدي Breast Cancer
Hemoglobin, EPO, & Iron dose figure 4
Figure 1.17 of the 2016 US Renal Data System Annual Data Report, Volume 2, chapter 1 showing the trends in the number of patients with incident ESRD (in.
2018 Annual Data Report Volume 3: Healthy People 2020
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
Volume 2: End-Stage Renal Disease
Volume 2: End-Stage Renal Disease
Number of dialysis & transplant units figure 10.1
Volume 64, Pages S3-S12 (December 2003)
CHAPTER 10 Hepatitis on Dialysis
New ESRD Patients and Main Sources
Anemia as a risk factor for chronic kidney disease
Cause Specific Death Rates for All Dialysis Patients
Reported ESRD Period and Point Prevalence,
Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study  Eric D.
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Renal replacement therapy in Latin America
Worldwide incidence of ESRD figure 12.1, per million population
Chapter 78 Vaccination and Screening in Cervical Cancer
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Maristela Böhlke, PhD  American Journal of Kidney Diseases 
New dialysis starts in the United States by year in patients with and without diagnosis of diabetes. New dialysis starts in the United States by year in.
Presentation transcript:

USRDS 2000 ADR USRDS Hepatitis B vaccine & antibody among patients & unit staff figure 9.1, dialysis patients, 1997, by network

USRDS 2000 ADR USRDS Percent of patients receiving hepatitis B vaccine figure 9.2, dialysis patients, 1997, by HSA Percent of patients

USRDS 2000 ADR USRDS Percent of unit staff receiving hepatitis B vaccine figure 9.3, 1997, by HSA Percent of unit staff

USRDS 2000 ADR USRDS Hepatitis C diagnosis rates figure 9.4, per 100 patient years at risk, incident & prevalent hemodialysis patients, 1998, by HSA Rate per 100 patient years at risk

USRDS 2000 ADR USRDS Hepatitis C diagnosis rates figure 9.5, per 100 patient years at risk, incident & prevalent peritoneal dialysis patients, 1998, by HSA Rate per 100 patient years at risk

USRDS 2000 ADR USRDS Hepatitis C diagnosis rates figure 9.6, per 100 patient years at risk, incident & prevalent transplant patients, 1998, by HSA Rate per 100 patient years at risk

USRDS 2000 ADR USRDS Breast cancer screening figure 9.7, all ESRD patients

USRDS 2000 ADR USRDS Cervical cancer screening figure 9.8, all ESRD patients

USRDS 2000 ADR USRDS Prostate cancer screening figure 9.9, all ESRD patients

USRDS 2000 ADR USRDS Diabetic eye exams figure 9.10, prevalent diabetic ESRD patients

USRDS 2000 ADR USRDS Glycosylated hemoglobin testing figure 9.11, prevalent diabetic ESRD patients

USRDS 2000 ADR USRDS Patients receiving influenza vaccine (%) figure 9.12, all ESRD patients, by HSA Percent of patients